###### Strengths and limitations of this study

First national survey of all 6--7-year olds for asthma prevalence.All three islands of Grenada (Grenada, Carriacou and Petite Martinique) were surveyed.Prevalence and severity were reported, with prevalence high for Grenada (∼30%).Self-report study by parents/guardians.No objective measurements of airway resistance.

Introduction {#s1}
============

Childhood asthma is one of the most significant childhood illnesses in terms of morbidity and mortality.[@R1] Asthma is a chronic inflammatory disorder of the airways that is characterised by variable and recurring symptoms including airway obstruction and bronchial hyperresponsiveness.[@R2] While there have been some studies suggesting that asthma prevalence worldwide is no longer increasing, a systematic review conducted in 2010 suggests a more complex geographical picture.[@R3] Most notably, there seems to be an increase in asthma prevalence in developing countries.[@R4] These findings are reiterated by surveys conducted by the International Survey of Asthma and Allergies in Childhood (ISAAC). These studies suggest that while many developed countries in North America and Western Europe have already reached their peak asthma prevalence, some developing countries of Latin America, Eastern Europe and the Caribbean continue to rise in asthma prevalence.[@R5]

Well-characterised triggers of asthma include exercise, cold air, inhaled allergens, cigarette smoke and upper respiratory viruses.[@R6] Asthma has also been linked to environmental factors, such as exposure to tobacco smoke and dust mites, and genetic risk factors.[@R4] Studies have demonstrated that individuals of Afro-Caribbean descent may carry a disproportionately large asthma burden.[@R7] In a 2010 study, age matched Black Caribbean boys were reported to have higher rates of asthma than White and Indian girls and boys.[@R8] Anecdotally and empirically, asthma prevalence rates are high in the Caribbean, where the vast majority of the population is of African descent.

Within the past 20 years, health officials and researchers in the Caribbean have begun tackling the emerging problem of asthma. In 1998, an asthma prevalence study conducted by Howitt *et al*[@R9] in Barbados concluded that over 16.8% of children aged 6--7 were diagnosed with asthma, and in 2005, Monteil *et al*[@R10] conducted a nationwide cross-sectional survey in Trinidad and Tobago and found that 12.8% of children aged between 11 and 19 years had been diagnosed with asthma and over 24% had prior wheezing experience. Moreover, in 2010 Kahwa *et al*[@R11] found that 16.7% of Jamaican children aged between of 2 and 17 were diagnosed as asthmatic.

To date, the Caribbean nation of Grenada, a country of 344 km^2^ with a population of 110 152, has not conducted an asthma prevalence study.[@R12] Grenada is a tri-island nation made up of the large island of Grenada housing about 94% of the nation\'s population, and the smaller islands of Carriacou and Petite Martinique as a single parish with the remaining 6% of the population.

According to the Grenada Ministry of Health (personal communication), over the past few years the most common cause of paediatric emergency department (ED) visits at the St. George\'s General Hospital has been due to asthma exacerbations. The direct (hospitalisations and medications) and indirect (school/work absenteeism) costs of asthma are significant, and seem to be increasing, making it an important public health issue.[@R13] Asthma is estimated to be among the highest costing chronic health conditions due to ED visits, hospital admissions, and medications.[@R13] Thus, asthma is not only a significant burden on the patient and caregivers, but also on the country\'s healthcare system. In Grenada, the large number of paediatric hospital visits makes the pursuit of a prevalence study, effective education, and therapy important.

Methods {#s2}
=======

Study design {#s2a}
------------

Following approval by the Institutional Review Board at St. George\'s University, Grenada\'s Ministry of Education and Human Resource Development and Ministry of Health and Social Security, a nationwide cross-sectional survey of all children aged 6--7 years was conducted throughout the 58 primary schools in Grenada, from October to December 2013. This age cohort matches the previous ISAAC studies.[@R5]

Data collection {#s2b}
---------------

Asthma symptoms were assessed using a modified version of the phase 1 ISAAC written questionnaire with accompanying parental/guardian consent forms. The questionnaires were anonymous, although participants were asked to complete demographic characteristics such as age, gender and parish of residence. The survey questions focused on characteristic symptoms of asthma, severity of symptoms, treatment regimens, healthcare usage, family history and exposure to possible risk factors. Owing to unique environmental exposures in Grenada, one question was added to the ISAAC questionnaire about exposure to burning brush (the burning of tree and grass trimmings is common in Grenada).

A trained representative, from the non-profit organisation Urban Humanitarian Projects of St. George\'s University School of Medicine, visited each of the primary schools to speak about the survey to the principals, teachers and children in grades 1, 2 and 3. Children brought a consent form and questionnaire back home to their parents to complete and return to the school for collection. Parents had an option of declining to participate in the survey by stating so on the provided forms. Of the returned surveys, those missing a date of birth or those outside the 2-year cross-sectional window of 1 January 2006 and 31 December 2007 were removed from the analysis.

Data analysis {#s2c}
-------------

Asthma diagnosis was based on previous physician diagnosed asthma and/or self-reported presence of wheeze in the past 12 months (current wheeze).[@R5] The primary outcome measure of asthma prevalence was calculated and then stratified by parish to detect any disproportionally affected areas through χ^2^ tests. Secondary outcomes, including severity of symptoms (categorised as either intermittent, mild, moderate or severe as per the US National Asthma Education and Prevention Program), were also stratified by gender and analysed with a 95% CI.[@R14]

To determine if there was an association between exposure to environmental irritants and the presence/exacerbation of asthmatic symptoms, the OR was calculated. Healthcare usage, as demonstrated by doctor visits, ED visits and number of medications taken were calculated and also stratified by severity of symptoms.

Results {#s3}
=======

Response rate {#s3a}
-------------

Of the 2362 surveys handed out to the school children, 1374 surveys were returned, resulting in a response rate of 58.2%. Females composed 53.6% of respondents and males composed the remaining 46.4%. Of the returned surveys only responders listing birthdays between 1 January 2006 and 31 December 2007 were included in the data analysis, resulting in a total of 1165 qualifying responders. The number of responses collected from each parish was correlated with the reported total populations from each parish (see online supplementary table S1). The survey responses, as stratified by parish, ranged from Saint George (28.8%) to Saint John (4.4%).

Current wheeze {#s3b}
--------------

In total, 30.5% of respondents reported the presence of symptomatic wheezing over a 12-month period, that is, *current wheeze.* The parishes with the highest prevalence were St. George, St. John and St. Andrew and the lowest was Carriacou and Petite Martinique ([table 1](#BMJOPEN2015008557TB1){ref-type="table"}A). Moreover, while the majority of respondents with current wheeze was previously diagnosed with asthma, 31.6% reported never being diagnosed by a physician (see online supplementary table S2). Parish population density, which varies widely in Grenada, was also compared with asthma rates as densities ranged from St. George (590 persons/km^2^, 33.7%) to Carriacou and Petite Martinique (179 persons/km^2^, 14.1%) (see online supplementary figure S1).

###### 

Asthma prevalence

                                                                                                                                                                                                            Current wheeze   No wheeze   Per cent   95% CI          p Value (X^2^)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------- ----------- ---------- --------------- ----------------
  *(A) Number of respondents, prevalence estimates (%) and 95% CI for current wheeze throughout Grenada, Petite Martinique and Carriacou*                                                                                                                           
  Grenada                                                                                                                                                                                                   355              810         30.5       27.8 to 33.1%   0.038
   Carriacou+Petite Martinique                                                                                                                                                                              11               67          14.1       6.4 to 21.8%    
   Saint Andrew                                                                                                                                                                                             102              210         32.7       27.5 to 37.9%   
   Saint David                                                                                                                                                                                              47               115         29.0       22.0 to 36.0%   
   Saint George                                                                                                                                                                                             112              220         33.7       28.6 to 38.8%   
   Saint John                                                                                                                                                                                               17               34          33.3       20.4 to 46.3%   
   Saint Mark                                                                                                                                                                                               22               48          31.4       20.6 to 42.3%   
   Saint Patrick                                                                                                                                                                                            44               116         27.5       20.6 to 34.4%   
  *(B) Number of respondents, prevalence estimates (%) and 95% CI of current wheeze among individuals with or without prior doctor diagnosed asthma throughout Grenada, Carriacou, and Petite Martinique*                                                           
  Prevalence Comparison                                                                                                                                                                                                                                             
   Carriacou+Petite Martinique                                                                                                                                                                              11               67          14.1       6.4 to 21.8%    0.0011
   Grenada                                                                                                                                                                                                  344              743         31.6       28.9 to 34.4%   

Survey respondents who reported past diagnosis of asthma were on average diagnosed at 2.07 (SE=0.099) years of age ([figure 1](#BMJOPEN2015008557F1){ref-type="fig"}A). Current wheeze respondents were significantly more likely to have family members with asthma ([figure 1](#BMJOPEN2015008557F1){ref-type="fig"}B). Grenadian boys (34.4%) were slightly more likely to report symptomatic wheezing than girls (27.7%) ([figure 1](#BMJOPEN2015008557F1){ref-type="fig"}C).

![(A) The frequency distribution of doctor diagnosed asthma by annual age bracket, with a mean age of diagnosis of 2.07±0.19 years. (B) the frequency distribution of current wheeze responders versus non-wheeze responders with familial history of asthma in a first or second degree relative. The frequency of current wheeze responders was significantly higher in those persons reporting any relative (p\<0.001), first degree relatives (p\<0.001) and second degree relatives (p\<0.01) with a history of asthma. (C) The frequency distribution of current wheeze responders by gender. The prevalence of current wheeze responders was significantly higher (p\<0.05) in males versus females by 5.70%.](bmjopen2015008557f01){#BMJOPEN2015008557F1}

Gender differences {#s3c}
------------------

Despite the difference in symptomatic wheezing between boys and girls, there was no significant difference in asthma severity between the sexes ([table 2](#BMJOPEN2015008557TB2){ref-type="table"}A). Males reported experiencing a higher frequency (ie, either daily or continuous) of cough, wheeze and shortness of breath when compared to their female counterparts ([table 2](#BMJOPEN2015008557TB2){ref-type="table"}B). However, there were no significant differences between the sexes when comparing exercise tolerance and school absences ([table 2](#BMJOPEN2015008557TB2){ref-type="table"}C, D).

###### 

Asthma severity and symptoms

                                                                                                                                                                                                                                                                                                                                         All     Female            Male                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ----------------- ------- ----------------- ------ -----------------
  (*A) The responder estimated severity of wheeze symptoms with 95% CI and gender comparison. Symptom severity is categorised as intermittent if the frequency of symptoms is less than 1 week, mild when occurring more than once a week but not daily, moderate if symptoms occur daily and persistent when symptoms are continuous*                                                              
  Asthma severity                                                                                                                                                                                                                                                                                                                        n=225   n=107             n=118                            
   Intermittent                                                                                                                                                                                                                                                                                                                          25.4    (19.8 to 31.1%)   28.0    (19.5 to 36.5%)   22.9   (15.3 to 30.5%)
   Mild                                                                                                                                                                                                                                                                                                                                  34.6    (28.4 to 40.8%)   33.6    (24.7 to 42.6%)   35.6   (27.0 to 44.2%)
   Moderate                                                                                                                                                                                                                                                                                                                              33.8    (27.7 to 39.9%)   30.8    (22.1 to 39.6%)   36.4   (27.7 to 45.1%)
   Severe                                                                                                                                                                                                                                                                                                                                6.1     (3.0 to 9.2%)     7.5     (2.5 to 12.5%)    5.1    (1.1 to 9.1%)
  (*B) The frequency of wheeze, cough or shortness of breath symptoms by current wheeze responders with 95% CI and gender comparison*                                                                                                                                                                                                                                                               
  Cough, wheeze, or shortness of breath                                                                                                                                                                                                                                                                                                  n=272   n=128             n=144                            
   Never                                                                                                                                                                                                                                                                                                                                 6.9     (3.9 to 9.9%)     7.3     (2.7 to 11.8%)    6.8    (2.7 to 10.9%)
   Less than 2×/week                                                                                                                                                                                                                                                                                                                     59.2    (53.4 to 65.0%)   59.7    (51.2 to 68.2%)   57.6   (49.5 to 65.6%)
   More than 2×/week                                                                                                                                                                                                                                                                                                                     28.1    (22.8 to 33.4%)   28.2    (20.4 to 36.0%)   28.8   (21.4 to 36.2%)
   Daily                                                                                                                                                                                                                                                                                                                                 5.8     (3.0 to 8.5%)     4.8     (1.1 to 8.5%)     6.8    (2.7 to 10.9%)
   Continuous                                                                                                                                                                                                                                                                                                                            6.1     (3.3 to 9.0%)     3.1     (0.1 to 6.1%)     8.3    (3.8 to 12.8%)
  *(C) The frequency of reported difficulty exercising with current wheeze responders with 95% CI and gender comparison*                                                                                                                                                                                                                                                                            
  Difficulty exercising                                                                                                                                                                                                                                                                                                                  n=279   n=134             n=145                            
   Never                                                                                                                                                                                                                                                                                                                                 37.4    (31.7 to 43.0%)   38.8    (30.6 to 47.1%)   35.9   (28.1 to 43.7%)
   Rare                                                                                                                                                                                                                                                                                                                                  25.3    (20.3 to 30.3%)   30.6    (22.8 to 38.4%)   37.9   (30.0 to 45.8%)
   Occasional                                                                                                                                                                                                                                                                                                                            34.2    (28.6 to 39.7%)   26.9    (19.4 to 34.4%)   23.4   (16.6 to 30.3%)
   Always                                                                                                                                                                                                                                                                                                                                3.2     (1.1 to 5.3%)     3.7     (0.5 to 6.9%)     2.8    (0.1 to 5.4%)
  (*D) The frequency of reported school absences with current wheeze responders with 95% CI and gender comparison*                                                                                                                                                                                                                                                                                  
  School absences due to symptoms                                                                                                                                                                                                                                                                                                        n=292   n=142             n=150                            
   Never                                                                                                                                                                                                                                                                                                                                 20.1    (15.5 to 24.6%)   23.2    (16.3 to 30.2%)   16.7   (10.7 to 22.6%)
   Rare                                                                                                                                                                                                                                                                                                                                  43.9    (38.2 to 49.5%)   42.3    (34.1 to 50.4%)   46.0   (38.0 to 54.0%)
   Occasional                                                                                                                                                                                                                                                                                                                            30.3    (25.0 to 35.5%)   28.9    (21.4 to 36.3%)   31.3   (23.9 to 38.8%)
   Always                                                                                                                                                                                                                                                                                                                                5.8     (3.1 to 8.5%)     5.6     (1.9 to 9.4%)     6.0    (2.2 to 9.8%)

Exposure to irritants {#s3d}
---------------------

Comparing the exposure of current wheeze and no wheeze respondents to known irritants, it was found that current wheeze respondents were more likely to be exposed to cigarette smoke (OR=1.80), excessive dust (OR=2.90), burning brush (OR=2.27) and landfills (OR=2.46) ([table 3](#BMJOPEN2015008557TB3){ref-type="table"}A). When comparing the exposure of respondents from the smaller islands of Carriacou and Petite Martinique with those from Grenada, residents of the former islands were found to have significantly decreased exposure to cigarette smoke (OR=0.41) and burning brush (OR=0.45) ([table 3](#BMJOPEN2015008557TB3){ref-type="table"}B). [Table 3](#BMJOPEN2015008557TB3){ref-type="table"}C indicates that exacerbation of asthmatic symptoms occurs when current wheeze respondents were exposed to known irritants including cigarette smoke, excessive dust, burning brush, pets at home and landfills.

###### 

Environmental irritants

                                                                                                                                                                              Cigarette smoke   Excessive dust   Burning brush   Pets at home    Landfills                                                
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- ---------------- --------------- --------------- ----------- --------------- ------ -------------- ------ ---------------
  *(A) The estimated frequency distribution of current wheeze and non-wheeze responders as a function of known environmental risk factors for asthma*                                                                                                                                                     
  All respondents (exposure)                                                                                                                                                                                                                                                                              
   Current wheeze                                                                                                                                                             47.7              1.80             40.3            2.90            59.7        2.27            60.5   1.16           11.4   2.46
   No wheeze in 12 months                                                                                                                                                     33.7              1.37 to 2.35     18.9            2.15 to 3.90    39.5        1.74 to 2.96    56.9   0.89 to 1.52   5.0    1.48 to 4.09
                                                                                                                                                                                                \<0.001                          \<0.001                     \<0.001                0.27                  \<0.001
  *(B) Comparison of the frequency of wheeze vs non-wheeze responders to environmental risk factors between Grenada and Carriacou/Petite Martinique*                                                                                                                                                      
  Tri-island comparison (exposure)                                                                                                                                                                                                                                                                        
   Carriacou+Petite Martinique                                                                                                                                                20.0              0.41             21.1            0.79            27.5        0.45            51.4   0.77           4.6    0.66
   Grenada                                                                                                                                                                    37.8              0.23 to 0.75     25.2            0.44 to 1.43    45.7        0.26 to 0.78    57.9   0.48 to 1.24   6.8    0.20 to 2.16
                                                                                                                                                                                                0.003                            0.438                       0.003                  0.276                 0.491
  *(C) The estimated frequency distribution of current wheeze vs non-wheeze responders reporting symptom exacerbation by exposure to environmental risk factors for asthma*                                                                                                                               
  All respondents (exacerbation with exposure)                                                                                                                                                                                                                                                            
   Current wheeze                                                                                                                                                             51.6              7.87             55.5            10.47           58.7        7.76            21.8   5.41           11.8   9.21
   No wheeze in 12 months                                                                                                                                                     11.9              5.74 to 10.80    10.6            7.54 to 14.54   15.5        5.75 to 10.48   4.9    3.50 to 8.37   1.4    4.44 to 19.07
                                                                                                                                                                                                \<0.001                          \<0.001                     \<0.001                \<0.001               \<0.001

Healthcare usage {#s3e}
----------------

Of the respondents, 230 reported doctor visits for asthma, with the majority reporting 1--2 visits annually with an average of 2.82 (95% CI of 2.42 to 3.22) ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}A). Respondents reported a total of 151 ED visits for asthma exacerbations with the majority reporting 1 visit in the past 12 months and eight individuals reporting more than 5 ED visits. The total range spanned from 0 to 12 ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}B). When the severity of asthma symptoms was compared to the number of doctor and ED visits, it was noted that individuals who listed their symptoms as severe had fewer doctor and more ED visits than individuals who reported moderate asthmatic symptoms ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}C).

![Healthcare burden of asthma among the current wheeze respondents for Grenada, Petitie Martinique and Carriacou. (A) the frequency distribution for the number of annual doctor visits relating to asthma. (n=230, total doctor visits=649, average annual visits=2.82±0.40) (B) the frequency distribution for the number of emergency department (ED) visits relating to asthma. (n=213, total ED visits=213, average annual hospitalisations=0.86±0.26) (C) Comparison of the average number of doctor and ED visits between diagnosed asthma patients reporting different severity of asthma symptoms. (D) The fraction of doctor diagnosed asthma patients with 1, 2, 3 or more current prescriptions for control of asthma symptoms. (E) Comparison of the average number of doctor and ED visits between medicated and non-medicated patients with current diagnosis of asthma. (F) Comparison of the average number of doctor and ED visits by patients with 1, 2, 3 or more current asthma medications. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](bmjopen2015008557f02){#BMJOPEN2015008557F2}

Of the 225 responders who reported about asthma medication, 34.4% reported the use of no medication, 18.1% reported the use of one, 32.6% reported the use of two, and 15.0% reported the use of three or more medications ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}D). Respondents taking medication, compared to those who were not taking medication, also reported increased annual rates of doctor and ED visits (3.78 vs 1.22 and 1.04 vs 0.28, respectively) ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}E). Additionally, when the number of medications a child reported taking was compared to the number of doctor and ED visits, it was found that children who reported taking three or more medications had fewer doctor and ED visits compared to children on only two medications ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}F).

Discussion {#s4}
==========

The response rate from this survey was 58.2%, which is comparable to previous studies performed in Trinidad with response rates of 54.0% and 73.3%.[@R10] [@R15] It was found that 30.5% of all respondents reported the presence of wheeze in the past 12 months, which places Grenada among countries with the highest prevalence of asthma including Costa Rica at 32.1% and Australia at 27.2% and significantly higher than the Global Initiative for Asthma (GINA) estimated prevalence of 10.4% in the Caribbean.[@R1] [@R16] Comparing the prevalence of asthma in Grenadian 6--7-year-olds to neighbouring Caribbean nations, Grenada demonstrates a higher asthmatic rate than Barbados at 18.3%, Trinidad and Tobago at 13.3% and Jamaica at 16.7%.[@R9]^--^[@R11] The difference between Grenada and neighbouring countries is surprising and should be explored further.

As Grenada is divided into separate parishes, part of the study was designed to determine significant regional variations. Among the six parishes that make up the largest island of Grenada, there were no significant differences in asthma rate despite known differences in healthcare resource distribution ([table 1](#BMJOPEN2015008557TB1){ref-type="table"}A). However, the parish of Carriacou and Petite Martinique demonstrated significantly decreased prevalence of asthmatic symptoms in comparison to Grenada ([table 1](#BMJOPEN2015008557TB1){ref-type="table"}B). One potential factor is that survey respondents from Carriacou and Petite Martinique reported decreased exposure to cigarette smoke and burning brush as compared to those of Grenada ([table 3](#BMJOPEN2015008557TB3){ref-type="table"}B). Carriacou and Petite Martinique also have significantly decreased population density (179 persons/km^2^) as compared to the rest of Grenada (311 persons/km^2^).[@R17] However, when parish population density was compared with asthma rates, there was no significant correlation between the factors, despite the large differences in population density (see online supplementary figure S1). Furthermore, studies thus far have not demonstrated a significant difference in asthma rates between dense urban areas and less-dense rural areas.[@R18] [@R19] These difference in asthma and irritant exposure rates between the islands warrants further research.

Estimating healthcare usage secondary to asthma was another goal for the study. Respondents with asthmatic symptoms averaged 2.88 doctor visits annually for asthma ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}A). In this same group, the respondents averaged 89 ED visits per 100 respondents annually for asthma exacerbations. The rate of hospital visits is troubling when compared to developed countries like the USA whose annual rates of ED visits for asthmatic patients aged 5--14 from 2007 to 2009 was 9.5/100.[@R20] The high hospitalisation rate in Grenada raises concerns about healthcare costs, overutilisation of limited resources, and increased patient morbidity.

One potential reason for the high number of ED visits could be limited and/or sporadic access to asthma medication. Of the symptomatic respondents, 65.6% reported being prescribed prescriptions for asthma management. However, two major factors in this population that may affect asthma control are the consistent availability of medications and compliance to prescribed medical regiments. It is also noted that patients reporting the use of two medications had the highest number of doctor and ED visits, whereas patients reporting the use of three of more medications, in comparison, had a lower number of doctor and ED visits ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}F). This could be due to the larger number of medications controlling asthmatic symptoms more effectively or the medications could proxy for greater physician involvement and thus better primary and preventative care.

Interestingly, when comparing symptomatic patients who are medicated to those who are non-medicated, the former have increased healthcare usage in doctor and hospital ED visits ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}E). Furthermore, it was found that the largest users of primary care health resources such as doctor visits were respondents with moderate symptoms of asthma, while the largest users of emergency healthcare resources were individuals who reported having severe asthma symptoms ([figure 2](#BMJOPEN2015008557F2){ref-type="fig"}C). This could be attributed to patients with more severe symptoms being less compliant with their treatment regimens and physician check-ups compared to individuals with milder symptoms. This lack of compliance would increase the likelihood of future asthma exacerbations, which require utilisation of more expensive emergency treatments.[@R13] Additionally, the out-of-pocket cost of healthcare, discrepancies in asthma education or medication use, and belief in traditional/alternative forms of medicine could also be contributors to poor compliance in the Grenadian population.

An added dimension to the complexity includes patients with difficult-to-control or refractory asthma. Four respondents indicated over 10 ED visits in the past year resulting in significant patient morbidity and hospital costs. Although these patients account for a small proportion of the total asthmatic population, these individuals typically use a large amount of healthcare resources such as physician visits, hospital admissions and medications.[@R21]

Exposure to irritants such as cigarette smoke, excessive dust, burning brush and landfills were found to be associated with asthmatic symptoms with exposure to excessive dust having the highest association ([table 3](#BMJOPEN2015008557TB3){ref-type="table"}A). Because of the respondent-dependent nature of this study, it is difficult to ascertain what constitutes exposure to the aforementioned irritants. Delineating these factors could be the focus of a future study.

Despite the significant findings, because this study is self-reported, there are some limitations. First, the survey response rate of participants could be biased by therapeutic misconception, resulting in a higher survey return rate from students/families with asthma than those without. Future studies could mitigate this problem by surveying an older demographic capable of filling out the survey on site, without parental participation or engaging more directly with patients and parents. Also, as the symptoms are self-reported, they may not correlate with clinically diagnosable asthma. Thus, objective measures of asthma, including spirometry or longitudinal peak flow tracking could help corroborate future survey results. Lastly, the functional literacy of the general population in Grenada could have contributed to a non-response bias. Although Grenada has a literacy rate of 94%, this does not preclude the respondents from finding the survey difficult to answer and choosing instead not to participate in the survey.[@R17] Test trials of questions to sample populations could be used in future studies to ensure proper comprehension of survey questions and minimise non-response bias from poor understanding.

Asthma remains a significant health issue in Grenada and other Caribbean nations; it causes substantial patient morbidity, stresses financial resources, and decreases productivity through school absences. The treatment of asthma, particularly asthma exacerbations, utilises significant amounts of medical and hospital resources, which can strain any healthcare system. This survey represents the first attempt at gathering cross-sectional data for the prevalence of asthma in Grenadian children and uncovers some surprising findings. Of note, the higher prevalence rate of asthma in Grenada (30.5%) compared to neighbouring Caribbean nations and the relatively decreased prevalence of asthma in Carriacou and Petite Martinique compared to Grenada. The results of this study provide important data about the burden of asthma on the patient and on the nation\'s healthcare expenditure. These findings lay the framework for understanding the asthma epidemic in Grenada. Future studies in Grenada should focus on identifying the modifiable, environmental drivers of asthma and creating cost-effective healthcare interventions that decrease emergency treatments and patient morbidity.
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